Patents by Inventor Mathias Gebauer

Mathias Gebauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9989524
    Abstract: The invention relates to a companion diagnostic antibody-like binding protein based on the humanized monoclonal antibody, DS6, to be used as diagnostic tool for in vivo detection and quantification of the tumor-associated MUC1-sialoglycotope, CA6.
    Type: Grant
    Filed: February 5, 2014
    Date of Patent: June 5, 2018
    Assignee: SANOFI
    Inventors: Jochen Kruip, Susanta K. Sarkar, Mathias Gebauer, Christian Lange, Ingo Focken
  • Patent number: 9844607
    Abstract: The invention relates to a companion diagnostic antibody-like binding protein based on the humanized monoclonal antibody, DS6, to be used as diagnostic tool for in vivo detection and quantification of the tumor-associated MUC1-sialoglycotope, CA6.
    Type: Grant
    Filed: February 5, 2014
    Date of Patent: December 19, 2017
    Assignees: SANOFI, THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
    Inventors: Jochen Kruip, Sanjiv S. Gambhir, Susanta K. Sarkar, Mathias Gebauer, Christian Lange, Ingo Focken, Richard Kimura, Arutselvan Natarajan, Ohad Ilovich
  • Patent number: 8835359
    Abstract: The present invention relates to a method of identifying a compound involved in pain, the use of Ctla2b nucleic acid or Ctla2b protein for identifying a compound involved in pain as well as methods of diagnosing algesia involving the same.
    Type: Grant
    Filed: May 24, 2011
    Date of Patent: September 16, 2014
    Assignee: Sanofi
    Inventors: Mathias Gebauer, Martin Michaelis, Danping Ding-Pfennigdorff, Anke M. Schulte, Daniel Ziemek, Christiane Metz-Weldmann
  • Publication number: 20140255305
    Abstract: The invention relates to a companion diagnostic antibody-like binding protein based on the humanized monoclonal antibody, DS6, to be used as diagnostic tool for in vivo detection and quantification of the tumor-associated MUC1-sialoglycotope, CA6.
    Type: Application
    Filed: February 5, 2014
    Publication date: September 11, 2014
    Inventors: Jochen Kruip, Sanjiv S. Gambhir, Susanta K. Sarkar, Mathias Gebauer, Christian Lange, Ingo Focken, Richard Kimura, Arutselvan Natarajan, Ohad Ilovich
  • Publication number: 20140256916
    Abstract: The invention relates to a companion diagnostic antibody-like binding protein based on the humanized monoclonal antibody, DS6, to be used as diagnostic tool for in vivo detection and quantification of the tumor-associated MUC1-sialoglycotope, CA6.
    Type: Application
    Filed: February 5, 2014
    Publication date: September 11, 2014
    Inventors: Jochen Kruip, Susanta K. Sarkar, Mathias Gebauer, Christian Lange, Ingo Focken
  • Patent number: 8673823
    Abstract: The present invention relates to a method of identifying a compound involved in pain, the use of Epsti1 nucleic acid or Epsti1 protein for identifying a compound involved in pain as well as methods of diagnosing algesia involving the same.
    Type: Grant
    Filed: March 17, 2011
    Date of Patent: March 18, 2014
    Assignee: Sanofi
    Inventors: Mathias Gebauer, Martin Michaelis, Danping Ding-Pfennigdorff, Anke M. Schulte, Daniel Ziemek, Christiane Metz-Weidmann
  • Publication number: 20130274120
    Abstract: The present invention relates to a method of identifying a compound involved in pain, the use of Ms4a6d nucleic acid or Ms4a6d protein for identifying a compound involved in pain as well as methods of diagnosing algesia involving the same.
    Type: Application
    Filed: May 24, 2011
    Publication date: October 17, 2013
    Applicant: SANOFI
    Inventors: Mathias Gebauer, Martin Michaelis, Danping Ding-Pfennigdorff, Anke M. Schulte, Daniel Ziemek, Christiane Metz-Weidmann
  • Publication number: 20130157890
    Abstract: The present invention relates to a method of identifying a compound involved in pain, the use of Ctla2b nucleic acid or Ctla2b protein for identifying a compound involved in pain as well as methods of diagnosing algesia involving the same.
    Type: Application
    Filed: May 24, 2011
    Publication date: June 20, 2013
    Applicant: SANOFI
    Inventors: Mathias Gebauer, Martin Michaelis, Danping Ding-Pfennigdorff, Anke M. Schulte, Daniel Ziemek, Christiane Metz-Weldmann
  • Publication number: 20130157880
    Abstract: The present invention relates to a method of identifying a compound involved in pain, the use of Car3 nucleic acid or Car3 protein for identifying a compound involved in pain as well as methods of diagnosing algesia involving the same.
    Type: Application
    Filed: January 20, 2011
    Publication date: June 20, 2013
    Applicant: SANOFI
    Inventors: Mathias Gebauer, Martin Michaelis, Danping Ding-Pfennigdorff, Anke M. Schulte, Daniel Ziemek, Christiane Metz-Weidmann
  • Publication number: 20130109582
    Abstract: The present invention relates to a method of identifying a compound involved in pain, the use of Epsti1 nucleic acid or Epsti1 protein for identifying a compound involved in pain as well as methods of diagnosing algesia involving the same.
    Type: Application
    Filed: March 17, 2011
    Publication date: May 2, 2013
    Applicant: SANOFI
    Inventors: Mathias Gebauer, Martin Michaelis, Danping Ding-Pfennigdorff, Anke M. Schulte, Daniel Ziemek, Christiane Metz-Weidmann
  • Publication number: 20130079238
    Abstract: The present invention relates to a method of identifying a compound involved in pain, the use of Irf8 nucleic acid or Irf8 protein for identifying a compound involved in pain as well as methods of diagnosing algesia involving the same.
    Type: Application
    Filed: March 17, 2011
    Publication date: March 28, 2013
    Applicant: SANOFI
    Inventors: Mathias Gebauer, Martin Michaells, Danping Ding-Pfennigdorff, Anke M. Schulte, Daniel Ziemek, Christiane Metz-Weidmann
  • Publication number: 20130079239
    Abstract: The present invention relates to a method of identifying a compound involved in pain, the use of Ifi205 nucleic acid or Ifi205 protein for identifying a compound involved in pain as well as methods of diagnosing algesia involving the same.
    Type: Application
    Filed: March 17, 2011
    Publication date: March 28, 2013
    Applicant: SANOFI
    Inventors: Mathias Gebauer, Martin Michaelis, Danping Ding-Pfennigdorff, Anke M. Schulte, Daniel Ziemek, Christiane Metz-Weidmann
  • Publication number: 20130059745
    Abstract: The present invention relates to a method of identifying a compound involved in pain, the use of Il2rg nucleic acid or Il2rg protein for identifying a compound involved in pain as well as methods of diagnosing algesia involving the same.
    Type: Application
    Filed: January 20, 2011
    Publication date: March 7, 2013
    Applicant: SANOFI
    Inventors: Mathias Gebauer, Martin Michaelis, Danping Ding-Pfennigdorff, Anke M. Schulte, Daniel Ziemek, Christiane Metz-Weidmann
  • Publication number: 20130053265
    Abstract: The present invention relates to a method of identifying a compound involved in pain, the use of Lrrfip1 nucleic acid or Lrrfip1 protein for identifying a compound involved in pain as well as methods of diagnosing algesia involving the same.
    Type: Application
    Filed: January 20, 2011
    Publication date: February 28, 2013
    Applicant: SANOFI
    Inventors: Mathias Gebauer, Martin Michaeils, Danping Ding-Pfennigdorff, Anke M. Schulte, Daniel Ziemek, Christiane Metz-Weidmann
  • Patent number: 8349567
    Abstract: Present invention concerns the use of Cathepsin C. Other aspects of the invention concern methods for screening pharmaceuticals, for diagnosing pain susceptibility and for the treatment of pain.
    Type: Grant
    Filed: March 21, 2009
    Date of Patent: January 8, 2013
    Assignee: SANOFI
    Inventors: Mathias Gebauer, Martin Michaelis, Danping Ding-Pfennigdorff, Anke Schulte, Christiane Metz-Weidmann
  • Publication number: 20120270749
    Abstract: The present invention relates to a method of identifying a compound involved in pain, the use of C1qb nucleic acid or C1qb protein for identifying a compound involved in pain as well as methods of diagnosing algesia involving the same.
    Type: Application
    Filed: November 4, 2010
    Publication date: October 25, 2012
    Applicant: SANOFI
    Inventors: Mathias Gebauer, Martin Michaelis, Danping Ding-Pfennigdorff, Anke M. Schulte, Daniel Ziemek, Christiane Metz-Weidmann
  • Publication number: 20120252878
    Abstract: Present invention concerns the use of Cathepsin H. Other aspects of the invention concern methods for screening pharmaceuticals, for diagnosing pain susceptibility and for the treatment of pain.
    Type: Application
    Filed: August 27, 2010
    Publication date: October 4, 2012
    Applicant: SANOFI
    Inventors: Mathias Gebauer, Martin Michaelis, Danping Ding-Pfennigdorff, Anke M. Schulte, Christiane Metz-Weidmann
  • Publication number: 20110177096
    Abstract: The present invention relates to nucleic acid arrays used to detect genes which are up or down regulated following a pain stimulus in a mammal. It further relates to the use of GPR151 in methods to detect pain or evaluate the effect of a compound on the level of pain in a mammal. Other aspects of the invention concern a method for screening pharmaceuticals, methods for the treatment of pain and a pharmaceutical composition comprising a GPR151 modulator for the treatment of pain.
    Type: Application
    Filed: May 9, 2009
    Publication date: July 21, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Mathias Gebauer, Martin Michaelis, Danping Ding-Pfennigdorff, Anke M. Schulte, Christiane Metz-Weidmann
  • Publication number: 20110091888
    Abstract: Present invention concerns the use of Cathepsin C. Other aspects of the invention concern methods for screening pharmaceuticals, for diagnosing pain susceptibility and for the treatment of pain.
    Type: Application
    Filed: March 21, 2009
    Publication date: April 21, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Mathias Gebauer, Martin Michaelis, Danping Ding-Pfennigdorf, Anke M. Schulte, Christiane Metz-Weidmann
  • Publication number: 20050186596
    Abstract: The present invention relates to plasmids or retroviral vectors comprising a human CD2 cell surface antigen fused in frame with a reporter gene and to methods of screening for a nucleic acid sequence encoding a protein comprising a signal sequence. In particular, methods are provided for screening for a nucleic acid sequence encoding a signal sequence protein that is regulated during a biological process.
    Type: Application
    Filed: December 29, 2004
    Publication date: August 25, 2005
    Applicant: FrankGen Biotechnologie AG
    Inventors: Harald Von Melchner, Mathias Gebauer, Thomas Beckers